Remove 2004 Remove Epilepsy Remove Patients
article thumbnail

Is weed legal in Greece?

The Cannigma

Greek drug laws have gone through a series of amendments since the passing of law nº 1729/87 in 1987, which had at its core a view of drug addicts as patients as opposed to criminals. A survey carried out in 2004 found that 8.6% What Greek law permits for medical patients? overall had used cannabis. Is CBD legal in Greece?

article thumbnail

How Cannabis Research is Affecting Parkinson’s Disease

The Joint Blog

Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s? Though trialing is relatively new and there is no clear scientific evidence as of yet, anecdotal evidence from patients is looking positive. This is not the first medicinal trial of its kind.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mondaq-Dentons(UK)European Union: Will Medical Cannabis Soon Be Part Of The European Single Market?

Cannabis Law Report

The different approaches on the legality of cultivation and use of (medical) cannabis in the member states have led to a policy paradox within the European Union, causing complications for patients in several member states.

article thumbnail

Election Brings Big Wins for Cannabis Legalization

Canna Care Docs

Initiative 65 (74%) passed over the Alternative 65A (32%)—the latter of which would have restricted medicinal cannabis to terminally ill patients. Medicinal cannabis was already approved in Montana in 2004. The passing initiative legalizes cannabis prescriptions for 22 medical conditions.

article thumbnail

Is weed legal in the UK?

The Cannigma

The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.